The Improvement of the Hepatic Histological Findings in a Patient with Non-alcoholic Steatohepatitis with Type 2 Diabetes after the Administration of the Sodium-glucose Cotransporter 2 Inhibitor Ipragliflozin

The patient was a 67-year-old woman with type 2 diabetes and non-alcoholic steatohepatitis (NASH). The administration of the sodium-glucose cotransporter 2 (SGLT2) inhibitor, ipragliflozin improved her liver dysfunction clinically and histologically. The serum alanine aminotransferase (ALT) and ferr...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Akihiko, Irahara, Aya, Nakano, Atsuko, Takata, Emi, Koketsu, Yuko, Kimata, Kunie, Senda, Eri, Yamada, Hajime, Ichikawa, Kazuhito, Fujimori, Takahiro, Sumida, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675935/
https://www.ncbi.nlm.nih.gov/pubmed/28924123
http://dx.doi.org/10.2169/internalmedicine.8754-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675935/
https://www.ncbi.nlm.nih.gov/pubmed/28924123
http://dx.doi.org/10.2169/internalmedicine.8754-16

Ejemplares similares